Strategic partnerships, expansion announcements, industry awards, leadership updates, and business milestones — the official corporate news from Laborate Pharmaceuticals India Ltd.
Featured Story
"Our new Research and Development Centre represents a deliberate investment in India's pharmaceutical innovation ecosystem — designed to translate scientific insight into medicines that reach patients faster, at higher quality, and at accessible cost." — Director of Research & Development, Laborate Pharmaceuticals India Ltd.
Laborate Pharmaceuticals India Ltd. has inaugurated its new Research & Development Centre in Chandigarh, Haryana, marking a major step in the company's transition from a contract manufacturer to an innovation-driven pharmaceutical enterprise. The centre houses formulation development laboratories, stability study suites, analytical chemistry divisions, and regulatory affairs coordination units — designed to support both generic development and biosimilar research programmes for the Indian and export markets.
Read Full Story
Recognised for outstanding contribution to pharmaceutical exports, Laborate receives the Export Excellence Award at the Pharmexil Annual Ceremony in New Delhi.
Read Full Story
A multi-year agreement secures reliable supply of essential medicines to Kenya's public health network, covering 22 critical formulations across primary care needs.
Read Full Story
The conclusion of a two-year facility expansion programme increases production capacity at our Himachal Pradesh flagship plant, enabling accelerated export delivery timelines.
Read Full Story
Two senior appointments to the Laborate leadership team strengthen international market development and quality governance as the company continues its global expansion.
Read Full Story
A contract manufacturing and development partnership leverages Laborate's EU-GMP certified facilities to supply finished formulations to the European and MENA pharmaceutical markets.
Read Full Story
Following a rigorous third-party audit, Laborate's oral solid dosage manufacturing line at Paonta Sahib has received EU-GMP certification, opening direct access to European pharmaceutical procurement.
Read Full Story
Laborate Pharmaceuticals celebrates four decades of manufacturing trusted medicines for Indian and international patients, reflecting on its journey from a domestic supplier to a global pharmaceutical exporter.
Read Full Story
The Laborate Healthcare Access Programme, operating in partnership with district health authorities across Haryana and Himachal Pradesh, has reached a significant community impact milestone.
Read Full Story
The greenfield facility — targeted for commissioning in 2027 — will specialise in sterile injectable and biologic-compatible manufacturing, expanding Laborate's product development horizon.
Read Full Story
Two new distribution partnerships extend Laborate's Africa footprint to include Tanzania and Ethiopia, bringing the company's African market presence to 12 countries across the continent.
Read Full Story
Laborate's continued investment in employee wellbeing, professional development, and workplace culture earns national recognition from Great Place to Work® India.
Read Full Story
Laborate's Annual Report for the financial year ended March 2025 documents record pharmaceutical export performance, expanded geographic reach, and sustained investment in manufacturing quality infrastructure.
Read Full StoryThe complete media kit — company profile, approved photography, brand guidelines, product portfolio overview, and key facts sheet — ready for editorial and broadcast use.
For interview requests, partnership enquiries, broadcast access, or to register as a media contact — our team responds within one business day.
